Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,880.50
-35.50 (-1.85%)
Aug 19, 2026, 3:30 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 615.4 billion as of August 19, 2026. Its market cap has increased by 17.07% in one year.
Market Cap
615.40B
Enterprise Value
536.15B
Revenue
291.84B
Ranking
n/a
PE Ratio
16.05
Stock Price
1,880.50
ChartMarket Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 615.40B, an increase of 308.04%. That is a compound annual growth rate of 4.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 615.40B | 17.68% |
| Dec 30, 2025 | 522.95B | -5.35% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.41T |
| Otsuka Holdings | 6.32T |
| Daiichi Sankyo Company | 4.97T |
| Astellas Pharma | 4.23T |
| Kyowa Kirin | 1.35T |
| Ono Pharmaceutical | 1.14T |
| JCR Pharmaceuticals | 64.19B |
| Perseus Proteomics | 2.67B |